Interobserver agreement in the application of the Sydney system to reversibility of gastritis after H. pylori was good. More strict criteria should be used for atrophy and to differentiate normal and mild chronic inflammation.
Clinicopathologic correlation offive cases ofcystadenomas of the liver are reported. All patients
were female and radical surgical procedure, total excision or resection was performed four times,
and partial excision once. In all patients the postoperative course was uneventful and they are all
alive and well. Examined by conventional histological and special immuno-histochemical stains
the tumors fulfilled diagnostic criteria for these rare cystic growths. The cyst wall was composed
of three, histologically distinct layers. From the viewpoint of histogenesis and differential
diagnosis immunohistochemical properties were analysed. CEA and EMA were demonstrated
in epithelial cells and Vimentin in stromal cells.
The case is reported of a 27 year old woman who had mixed connective tissue disease (MCTD) associated with chronic active hepatitis and thyroiditis. Although hepatomegaly is sometimes observed in MCTD, only four cases of MCTD and chronic active hepatitis have been described. It is thought that this is the first report of an association between MCTD, chronic active hepatitis and thyroiditis.The association of mixed connective tissue disease (MCTD) and autoimmune hepatitis is rare. Only a few cases have been reported.1-3 MCTD associated with thyroiditis has not yet been described and it is suggested that the following case is the first example of a patient with MCTD and autoimmune hepatitis and thyroiditis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.